相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up study
Hiroki Nishiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation
Adele L. Richart et al.
CIRCULATION RESEARCH (2020)
2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
Francois Mach et al.
RUSSIAN JOURNAL OF CARDIOLOGY (2020)
Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD
Ki Heon Nam et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease
Kongyong Cui et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
Archna Bajaj et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2018)
Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document
Hector M. Garcia-Garcia et al.
CIRCULATION (2018)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
CIRCULATION (2018)
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease
Hamid Moradi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease
Julio A. Lamprea-Montealegre et al.
HEART (2018)
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins
Baiba K. Gillard et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
HDL in CKD-The Devil Is in the Detail
Florian Kronenberg
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Makoto Kinoshita et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression
Benjamin Bowe et al.
KIDNEY INTERNATIONAL (2016)
Apolipoprotein A-I: A Molecule of Diverse Function
Manaswini Mangaraj et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2016)
Cholesterol Metabolism in CKD
Allison B. Reiss et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis
Chantal Kopecky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: The ARIC Study
Julio A. Lamprea-Montealegre et al.
ATHEROSCLEROSIS (2014)
Trends in Cause of Death After Percutaneous Coronary Intervention
Daniel B. Spoon et al.
CIRCULATION (2014)
Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI
Frants Pedersen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Glycation of Apoprotein A-I Is Associated With Coronary Artery Plaque Progression in Type 2 Diabetic Patients
Li Jin Pu et al.
DIABETES CARE (2013)
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Maryam Zamanian-Daryoush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
High-density lipoproteins: A consensus statement from the National Lipid Association
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort et al.
LANCET (2013)
Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis
Tetsuo Shoji et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2012)
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples
Oemer-Necmi Goek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
Estelle Nobecourt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
Michelle A. Fryirs et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis
Borja Ibanez et al.
ATHEROSCLEROSIS (2009)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-IMilano (ETC-216) administration -: Magnetic resonance imaging study in an experimental model of atherosclerosis
Borja Ibanez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Familial risk assessment for early-onset coronary heart disease
Maren T. Scheuner et al.
GENETICS IN MEDICINE (2006)
Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level
I Sakurabayashi et al.
CLINICA CHIMICA ACTA (2001)
分享论文
